Polymer Therapeutics, Inc.

Polymer Therapeutics, Inc.

BioNJ Member Type: Core

Polymer Therapeutics, Inc. (PRx) has developed a novel class of biocompatible, bioabsorbable polymer-drugs (BPD™) having broad applications in the wound care and broader medical device markets. PRx’s technology incorporates common drug compounds, such as the NSAIDs salicylic acid (SA) and Diflunisal (DF), directly into the chemical structure of the polymer chain itself to produce the BPDs™ PolySA and PolyDF. These formulations allow the controlled delivery of BPDs™ with strong anti-inflammatory, analgesic and antiseptic properties directly at the injury site to promote healing. In addition, the polymer structure can be synthesized with a number of other active compounds including antibiotics to enhance the wound healing process. A key feature of this novel chemistry formulation is that the active compound is synthesized into a polymeric structure and thus becomes an integral part of the polymer backbone. As such, BPDs™ can be used to coat or even fabricate most any medical device.


P.O. Box 519
Gladstone, NJ 07934